Microbot Medical (MBOT) Cash & Current Investments (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Cash & Current Investments data on file, last reported at $69.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 155.86% year-over-year to $69.6 million; the trailing twelve-month figure through Mar 2026 stood at $69.6 million (up 155.86% YoY), and the FY2025 full-year result was $78.6 million, up 1336.78% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $69.6 million, down from $78.6 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $80.2 million in Q3 2025 and bottomed at $2.1 million in Q3 2022.
• The 5-year median for Cash & Current Investments is $6.4 million (2023), against an average of $20.3 million.
• The widest annual swing landed in 2022, when Cash & Current Investments plunged 90.91%; it then soared 1747.81% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $2.4 million in 2022, then surged by 161.15% to $6.4 million in 2023, then decreased by 14.33% to $5.5 million in 2024, then soared by 1336.78% to $78.6 million in 2025, then retreated by 11.38% to $69.6 million in 2026.
• The last three Cash & Current Investments figures came in at $69.6 million (Q1 2026), $78.6 million (Q4 2025), and $80.2 million (Q3 2025), per Business Quant data.

Peer Comparison